Fig. 2From: An analysis of DPV and DIVE registry patients with chronic kidney disease according to the finerenone phase III clinical trial selection criteriaPatients’ CKD characteristics: comparison of DPV/DIVE population (n = 65,168) with FIDELITY clinical trial populations. The figure describes the proportion of patients in the FIDELITY and the DIVE/DPV analysis respectively by subgroups defined by albuminuria and eGFR. eFGR, estimated glomerular filtration rateBack to article page